Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
The Journal of Investigative Dermatology
|
November 6, 2018
The Comparison of Skin Transcriptomes Confirms Canine Atopic Dermatitis Is a Natural Homologue to the Human Disease
Johannes M Freudenberg, Thierry Olivry, David N Mayhew, et al.
The Journal of Investigative Dermatology
|
February 17, 2016
Milestones in Investigative Dermatology: The Desmosome
Andrew P Kowalczyk, David S Rubenstein, David R Garrod, et al.
Journal of the American Academy of Dermatology
|
June 6, 2020
Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis
Amy S Paller, Linda Stein Gold, Jennifer Soung, et al.
Biochimica Et Biophysica Acta
|
July 31, 2002
New member of the trefoil factor family of proteins is an alpha-macroglobulin protease inhibitor
Ida B Thøgersen, Stephen R Hammes, David S Rubenstein, et al.
The Journal of Biological Chemistry
|
March 10, 2009
Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis
Hua En Lee, Paula Berkowitz, Puneet S Jolly, et al.
The Journal of Biological Chemistry
|
January 23, 2010
p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis
Puneet S Jolly, Paula Berkowitz, Meryem Bektas, et al.
The Journal of Biological Chemistry
|
March 12, 2011
The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid
Lisa Heimbach, Zhuowei Li, Paula Berkowitz, et al.
The Journal of Biological Chemistry
|
April 21, 2005
Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization
Paula Berkowitz, Peiqi Hu, Zhi Liu, et al.
American Journal of Clinical Dermatology
|
March 24, 2025
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis
Amy S Paller, Adelaide A Hebert, Mercedes E Gonzalez, et al.
Journal of Drugs in Dermatology : JDD
|
February 2, 2024
Targeting the Aryl Hydrocarbon Receptor to Address the Challenges of Atopic Dermatitis
Lawrence F Eichenfield, Jonathan I Silverberg, Adelaide A Hebert, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
The Journal of Investigative Dermatology
|
November 6, 2018
The Comparison of Skin Transcriptomes Confirms Canine Atopic Dermatitis Is a Natural Homologue to the Human Disease
Johannes M Freudenberg, Thierry Olivry, David N Mayhew, et al.
The Journal of Investigative Dermatology
|
February 17, 2016
Milestones in Investigative Dermatology: The Desmosome
Andrew P Kowalczyk, David S Rubenstein, David R Garrod, et al.
Journal of the American Academy of Dermatology
|
June 6, 2020
Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis
Amy S Paller, Linda Stein Gold, Jennifer Soung, et al.
Biochimica Et Biophysica Acta
|
July 31, 2002
New member of the trefoil factor family of proteins is an alpha-macroglobulin protease inhibitor
Ida B Thøgersen, Stephen R Hammes, David S Rubenstein, et al.
The Journal of Biological Chemistry
|
March 10, 2009
Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis
Hua En Lee, Paula Berkowitz, Puneet S Jolly, et al.
The Journal of Biological Chemistry
|
January 23, 2010
p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis
Puneet S Jolly, Paula Berkowitz, Meryem Bektas, et al.
The Journal of Biological Chemistry
|
March 12, 2011
The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid
Lisa Heimbach, Zhuowei Li, Paula Berkowitz, et al.
The Journal of Biological Chemistry
|
April 21, 2005
Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization
Paula Berkowitz, Peiqi Hu, Zhi Liu, et al.
American Journal of Clinical Dermatology
|
March 24, 2025
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis
Amy S Paller, Adelaide A Hebert, Mercedes E Gonzalez, et al.
Journal of Drugs in Dermatology : JDD
|
February 2, 2024
Targeting the Aryl Hydrocarbon Receptor to Address the Challenges of Atopic Dermatitis
Lawrence F Eichenfield, Jonathan I Silverberg, Adelaide A Hebert, et al.
Page
of 6